Selected research
Market Structure
Global AI Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Drug Discovery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Drug Discovery include Recursion, Insilico Medicine, Schrödinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics and BenevolentAI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Drug Discovery market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Drug Discovery and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Drug Discovery revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Discovery market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Drug Discovery Segment by Company
Recursion
Insilico Medicine
Schrödinger
DeepMind
Insitro
Generate Biomedicines
XtalPi
Relay Therapeutics
BenevolentAI
Roivant Sciences
Ginkgo Bioworks
Exscientia
Merck KGaA
Novartis
Biotus
Huazhi Bio
MindRank AI
Ubigene
WuXi AppTec
AI Drug Discovery Segment by Type
Machine Learning Type
Deep Learning Type
Natural Language Processing Type
Data Mining Type
AI Drug Discovery Segment by Application
Target Discovery and Validation
Virtual Screening and Molecular Docking
Drug Repurposing and Precision Medicine
Clinical Data Analysis and Optimization
AI Drug Discovery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Discovery industry.
Chapter 3: Detailed analysis of AI Drug Discovery companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discoveryrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Machine Learning Type
- Deep Learning Type
- Natural Language Processing Type
- Data Mining Type
Applications
- Target Discovery and Validation
- Virtual Screening and Molecular Docking
- Drug Repurposing and Precision Medicine
- Clinical Data Analysis and Optimization
Companies covered
- Recursion
- Insilico Medicine
- Schrödinger
- DeepMind
- Insitro
- Generate Biomedicines
- XtalPi
- Relay Therapeutics
- BenevolentAI
- Roivant Sciences
- Ginkgo Bioworks
- Exscientia
- Merck KGaA
- Novartis
- Biotus
- Huazhi Bio
- MindRank AI
- Ubigene
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Drug Discovery Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Machine Learning Type
- 1.2.3 Deep Learning Type
- 1.2.4 Natural Language Processing Type
- 1.2.5 Data Mining Type
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Drug Discovery Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Target Discovery and Validation
- 1.3.3 Virtual Screening and Molecular Docking
- 1.3.4 Drug Repurposing and Precision Medicine
- 1.3.5 Clinical Data Analysis and Optimization
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Drug Discovery Growth Trends by Region
- 1.5.1 Global AI Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Drug Discovery Market Size by Region (2021-2026)
- 1.5.3 AI Drug Discovery Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Drug Discovery Market Dynamics
- 2.1 AI Drug Discovery Industry Trends
- 2.2 AI Drug Discovery Industry Drivers
- 2.3 AI Drug Discovery Industry Opportunities and Challenges
- 2.4 AI Drug Discovery Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Drug Discovery Revenue by Company (2021-2026)
- 3.2 Global AI Drug Discovery Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Drug Discovery Key Company Head office and Area Served
- 3.4 Global AI Drug Discovery Company, Product Type & Application
- 3.5 Global AI Drug Discovery Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Drug Discovery Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Drug Discovery Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Drug Discovery Tier 1, Tier 2, and Tier 3
4 AI Drug Discovery Market by Type
- 4.1 Global AI Drug Discovery Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Drug Discovery Market Size by Type (2021-2032)
- 4.3 Global AI Drug Discovery Market Size Share by Type (2021-2032)
5 AI Drug Discovery Market by Application
- 5.1 Global AI Drug Discovery Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Drug Discovery Market Size by Application (2021-2032)
- 5.3 Global AI Drug Discovery Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Recursion
- 6.1.1 Recursion Company Information
- 6.1.2 Recursion Business Overview
- 6.1.3 Recursion AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Recursion AI Drug Discovery Product Portfolio
- 6.1.5 Recursion Recent Developments
- 6.2 Insilico Medicine
- 6.2.1 Insilico Medicine Company Information
- 6.2.2 Insilico Medicine Business Overview
- 6.2.3 Insilico Medicine AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Insilico Medicine AI Drug Discovery Product Portfolio
- 6.2.5 Insilico Medicine Recent Developments
- 6.3 Schrödinger
- 6.3.1 Schrödinger Company Information
- 6.3.2 Schrödinger Business Overview
- 6.3.3 Schrödinger AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Schrödinger AI Drug Discovery Product Portfolio
- 6.3.5 Schrödinger Recent Developments
- 6.4 DeepMind
- 6.4.1 DeepMind Company Information
- 6.4.2 DeepMind Business Overview
- 6.4.3 DeepMind AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 DeepMind AI Drug Discovery Product Portfolio
- 6.4.5 DeepMind Recent Developments
- 6.5 Insitro
- 6.5.1 Insitro Company Information
- 6.5.2 Insitro Business Overview
- 6.5.3 Insitro AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Insitro AI Drug Discovery Product Portfolio
- 6.5.5 Insitro Recent Developments
- 6.6 Generate Biomedicines
- 6.6.1 Generate Biomedicines Company Information
- 6.6.2 Generate Biomedicines Business Overview
- 6.6.3 Generate Biomedicines AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Generate Biomedicines AI Drug Discovery Product Portfolio
- 6.6.5 Generate Biomedicines Recent Developments
- 6.7 XtalPi
- 6.7.1 XtalPi Company Information
- 6.7.2 XtalPi Business Overview
- 6.7.3 XtalPi AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 XtalPi AI Drug Discovery Product Portfolio
- 6.7.5 XtalPi Recent Developments
- 6.8 Relay Therapeutics
- 6.8.1 Relay Therapeutics Company Information
- 6.8.2 Relay Therapeutics Business Overview
- 6.8.3 Relay Therapeutics AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Relay Therapeutics AI Drug Discovery Product Portfolio
- 6.8.5 Relay Therapeutics Recent Developments
- 6.9 BenevolentAI
- 6.9.1 BenevolentAI Company Information
- 6.9.2 BenevolentAI Business Overview
- 6.9.3 BenevolentAI AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 BenevolentAI AI Drug Discovery Product Portfolio
- 6.9.5 BenevolentAI Recent Developments
- 6.10 Roivant Sciences
- 6.10.1 Roivant Sciences Company Information
- 6.10.2 Roivant Sciences Business Overview
- 6.10.3 Roivant Sciences AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Roivant Sciences AI Drug Discovery Product Portfolio
- 6.10.5 Roivant Sciences Recent Developments
- 6.11 Ginkgo Bioworks
- 6.11.1 Ginkgo Bioworks Company Information
- 6.11.2 Ginkgo Bioworks Business Overview
- 6.11.3 Ginkgo Bioworks AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Ginkgo Bioworks AI Drug Discovery Product Portfolio
- 6.11.5 Ginkgo Bioworks Recent Developments
- 6.12 Exscientia
- 6.12.1 Exscientia Company Information
- 6.12.2 Exscientia Business Overview
- 6.12.3 Exscientia AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Exscientia AI Drug Discovery Product Portfolio
- 6.12.5 Exscientia Recent Developments
- 6.13 Merck KGaA
- 6.13.1 Merck KGaA Company Information
- 6.13.2 Merck KGaA Business Overview
- 6.13.3 Merck KGaA AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Merck KGaA AI Drug Discovery Product Portfolio
- 6.13.5 Merck KGaA Recent Developments
- 6.14 Novartis
- 6.14.1 Novartis Company Information
- 6.14.2 Novartis Business Overview
- 6.14.3 Novartis AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Novartis AI Drug Discovery Product Portfolio
- 6.14.5 Novartis Recent Developments
- 6.15 Biotus
- 6.15.1 Biotus Company Information
- 6.15.2 Biotus Business Overview
- 6.15.3 Biotus AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Biotus AI Drug Discovery Product Portfolio
- 6.15.5 Biotus Recent Developments
- 6.16 Huazhi Bio
- 6.16.1 Huazhi Bio Company Information
- 6.16.2 Huazhi Bio Business Overview
- 6.16.3 Huazhi Bio AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Huazhi Bio AI Drug Discovery Product Portfolio
- 6.16.5 Huazhi Bio Recent Developments
- 6.17 MindRank AI
- 6.17.1 MindRank AI Company Information
- 6.17.2 MindRank AI Business Overview
- 6.17.3 MindRank AI AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 MindRank AI AI Drug Discovery Product Portfolio
- 6.17.5 MindRank AI Recent Developments
- 6.18 Ubigene
- 6.18.1 Ubigene Company Information
- 6.18.2 Ubigene Business Overview
- 6.18.3 Ubigene AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Ubigene AI Drug Discovery Product Portfolio
- 6.18.5 Ubigene Recent Developments
- 6.19 WuXi AppTec
- 6.19.1 WuXi AppTec Company Information
- 6.19.2 WuXi AppTec Business Overview
- 6.19.3 WuXi AppTec AI Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 WuXi AppTec AI Drug Discovery Product Portfolio
- 6.19.5 WuXi AppTec Recent Developments
7 North America
- 7.1 North America AI Drug Discovery Market Size (2021-2032)
- 7.2 North America AI Drug Discovery Market Size by Type
- 7.2.1 North America AI Drug Discovery Market Size by Type (2021-2026)
- 7.2.2 North America AI Drug Discovery Market Size by Type (2027-2032)
- 7.2.3 North America AI Drug Discovery Market Share by Type (2021-2032)
- 7.3 North America AI Drug Discovery Market Size by Application
- 7.3.1 North America AI Drug Discovery Market Size by Application (2021-2026)
- 7.3.2 North America AI Drug Discovery Market Size by Application (2027-2032)
- 7.3.3 North America AI Drug Discovery Market Share by Application (2021-2032)
- 7.4 North America AI Drug Discovery Market Size by Country
- 7.4.1 North America AI Drug Discovery Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Drug Discovery Market Size by Country (2021-2026)
- 7.4.3 North America AI Drug Discovery Market Size by Country (2027-2032)
- 7.4.4 North America AI Drug Discovery Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Drug Discovery Market Size (2021-2032)
- 8.2 Europe AI Drug Discovery Market Size by Type
- 8.2.1 Europe AI Drug Discovery Market Size by Type (2021-2026)
- 8.2.2 Europe AI Drug Discovery Market Size by Type (2027-2032)
- 8.2.3 Europe AI Drug Discovery Market Share by Type (2021-2032)
- 8.3 Europe AI Drug Discovery Market Size by Application
- 8.3.1 Europe AI Drug Discovery Market Size by Application (2021-2026)
- 8.3.2 Europe AI Drug Discovery Market Size by Application (2027-2032)
- 8.3.3 Europe AI Drug Discovery Market Share by Application (2021-2032)
- 8.4 Europe AI Drug Discovery Market Size by Country
- 8.4.1 Europe AI Drug Discovery Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Drug Discovery Market Size by Country (2021-2026)
- 8.4.3 Europe AI Drug Discovery Market Size by Country (2027-2032)
- 8.4.4 Europe AI Drug Discovery Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Drug Discovery Market Size (2021-2032)
- 9.2 China AI Drug Discovery Market Size by Type
- 9.2.1 China AI Drug Discovery Market Size by Type (2021-2026)
- 9.2.2 China AI Drug Discovery Market Size by Type (2027-2032)
- 9.2.3 China AI Drug Discovery Market Share by Type (2021-2032)
- 9.3 China AI Drug Discovery Market Size by Application
- 9.3.1 China AI Drug Discovery Market Size by Application (2021-2026)
- 9.3.2 China AI Drug Discovery Market Size by Application (2027-2032)
- 9.3.3 China AI Drug Discovery Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Drug Discovery Market Size (2021-2032)
- 10.2 Asia AI Drug Discovery Market Size by Type
- 10.2.1 Asia AI Drug Discovery Market Size by Type (2021-2026)
- 10.2.2 Asia AI Drug Discovery Market Size by Type (2027-2032)
- 10.2.3 Asia AI Drug Discovery Market Share by Type (2021-2032)
- 10.3 Asia AI Drug Discovery Market Size by Application
- 10.3.1 Asia AI Drug Discovery Market Size by Application (2021-2026)
- 10.3.2 Asia AI Drug Discovery Market Size by Application (2027-2032)
- 10.3.3 Asia AI Drug Discovery Market Share by Application (2021-2032)
- 10.4 Asia AI Drug Discovery Market Size by Country
- 10.4.1 Asia AI Drug Discovery Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Drug Discovery Market Size by Country (2021-2026)
- 10.4.3 Asia AI Drug Discovery Market Size by Country (2027-2032)
- 10.4.4 Asia AI Drug Discovery Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Drug Discovery Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Drug Discovery Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Drug Discovery Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Drug Discovery Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Drug Discovery Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Drug Discovery Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Drug Discovery Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Drug Discovery Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Drug Discovery Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Drug Discovery Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Drug Discovery Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Drug Discovery Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Drug Discovery Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Drug Discovery Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst